News Archives
February 5, 2020
Axial Biotherapeutics to Present at the Centre for Clinical Trials in Rare Neurodevelopmental Disorders’ Emerging Management Therapies for Childhood Neurodevelopmental Disorders Scientific Symposium
February 12, 2020
Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team
March 10, 2020
Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual Summit
April 02, 2020
Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder
November 25, 2020
Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 16, 2020
Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci Capital
September 22, 2020
Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical Science
September 15, 2020
Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
July 28, 2020
Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease Therapeutics
May 27, 2020
Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare Conference
May 22, 2020
Axial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual Meeting
December 3, 2020
Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other Symptoms
December 8, 2020
Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference
December 30, 2020
Axial Therapeutics to Present at the ACCESS CHINA Forum @JPM WEEK 2021